All In MedTech

FDA Clearance Tracker · P030016-S036

Visian ICL (Implantable Collamer Lens)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 15, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 15, 2019

Approved

Time to decision

164 days

Received Nov 2, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030016-S036
Device name
Visian ICL (Implantable Collamer Lens)
Applicant location
Monrovia, CA
Received
Nov 2, 2018
Decided
Apr 15, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P030016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MTA

FDA's approval statement

As written in FDA's record.

Approval for modification to the labeling for the Visian® Implantable Collamer® Lens, Models MICL and TMICL to reflect the findings of the Adverse Event Post-approval Study for the Visian® MICL

Source documents

Other decisions for STAAR Surgical Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.